Labcorp Holdings Inc. logo
Labcorp Holdings Inc. (LH)
Compare

Labcorp Holdings Inc. (LH) Return on Assets (ROA): 4.93%

Is Labcorp Holdings Inc.’s return on assets (ROA) high or low?

Labcorp Holdings Inc.'s return on assets (ROA) of 4.93% is 20% below its 5-year average of 6.18%, near the low end of its 5-year range (2.50%–11.66%).

As of Thursday, June 18, 2026. 11.66% above its 12-month average of 4.41%.

LH Return on Assets (ROA) Chart

LH Return on Assets (ROA)
4.77%+17.49% 1Y
Zoom

LH Average Return on Assets (ROA) Chart

LH Current vs Average Return on Assets (ROA) Chart

LH Return on Assets (ROA) Metrics

RETURN ON ASSETS (ROA)

4.93%

RETURN ON ASSETS (ROA) AVG TTM

4.41%

RETURN ON ASSETS (ROA) AVG 3Y

4.42%

RETURN ON ASSETS (ROA) AVG 5Y

6.18%

RETURN ON ASSETS (ROA) AVG 10Y

5.72%

RETURN ON ASSETS (ROA) AVG 15Y

6.51%

RETURN ON ASSETS (ROA) AVG 20Y

7.48%

CURRENT VS TTM AVG

+11.66%

CURRENT VS 3Y AVG

+11.54%

CURRENT VS 5Y AVG

-20.25%

CURRENT VS 10Y AVG

-13.88%

CURRENT VS 15Y AVG

-24.32%

CURRENT VS 20Y AVG

-34.09%

LH Competitors' Return on Assets (ROA)

NAMEMARKET CAPRETURN ON ASSETS (ROA)TTM3Y5Y
Labcorp Holdings Inc. (LH)$21.28B4.93%4.41%4.42%6.18%
Mettler-Toledo International Inc. (MTD)vs ›$22.83B23.85%25.02%24.63%23.85%
BioNTech SE (BNTX)vs ›$23.27B-6.03%-3.96%9.16%17.06%
United Therapeutics Corporation (UTHR)vs ›$23.41B19.17%16.59%14.73%13.22%
Waters Corporation (WAT)vs ›$23.53B1.83%13.34%15.53%17.15%
Moderna, Inc. (MRNA)vs ›$24.52B-27.80%-24.02%-10.32%-0.33%
Hologic, Inc. (HOLX)vs ›$16.97B5.92%7.45%8.56%11.79%
Veeva Systems Inc. (VEEV)vs ›$25.96B10.31%9.93%9.72%10.43%
DexCom, Inc. (DXCM)vs ›$27.49B14.03%11.04%9.26%8.83%
IQVIA Holdings Inc. (IQV)vs ›$28.48B4.67%4.82%4.76%4.01%

Asset Efficiency

ROA

4.9%

ROE

10.8%

Labcorp Holdings Inc. Return on Assets (ROA) Formula & Definition

ROA = Net Income / Total Assets

Return on assets measures how efficiently a company generates profit from its total assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Labcorp Holdings Inc. Return on Assets (ROA) FAQ

What is the return on assets (ROA) for Labcorp Holdings Inc. (LH)?
The return on assets (ROA) for LH stock is 4.93%.
Is Labcorp Holdings Inc.'s return on assets (ROA) high or low?
Labcorp Holdings Inc.'s return on assets (ROA) of 4.93% is 20% below its 5-year average of 6.18%, near the low end of its 5-year range (2.50%–11.66%).
What is the TTM average return on assets (ROA) for Labcorp Holdings Inc. (LH)?
The TTM average return on assets (ROA) for LH stock is 4.41%.
What is the 3Y average return on assets (ROA) for Labcorp Holdings Inc. (LH)?
The 3Y average return on assets (ROA) for LH stock is 4.42%.
What is the 5Y average return on assets (ROA) for Labcorp Holdings Inc. (LH)?
The 5Y average return on assets (ROA) for LH stock is 6.18%.
What is the 10Y average return on assets (ROA) for Labcorp Holdings Inc. (LH)?
The 10Y average return on assets (ROA) for LH stock is 5.72%.
What is the 15Y average return on assets (ROA) for Labcorp Holdings Inc. (LH)?
The 15Y average return on assets (ROA) for LH stock is 6.51%.
What is the 20Y average return on assets (ROA) for Labcorp Holdings Inc. (LH)?
The 20Y average return on assets (ROA) for LH stock is 7.48%.

Labcorp Holdings Inc. Return on Assets (ROA) History

DATERETURN ON ASSETS (ROA)
2025-12-314.77%
2024-12-314.06%
2023-12-312.50%
2022-12-316.35%
2021-12-3111.66%
2020-12-317.75%
2019-12-314.57%
2018-12-315.46%
2017-12-317.65%
2016-12-315.14%
2015-12-313.06%
2014-12-317.00%
2013-12-318.26%
2012-12-318.56%
2011-12-318.42%
2010-12-319.02%
2009-12-3111.23%
2008-12-319.95%
2007-12-3110.92%
2006-12-3110.79%
2005-12-319.96%
2004-12-3110.08%
2003-12-319.40%
2002-12-319.75%
2001-12-319.30%
2000-12-316.73%
1999-12-314.11%
1998-12-314.19%
1997-12-31-6.45%
1996-12-31-8.01%

About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Burlington, NC
60,900 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Adam H. Schechter